期刊文献+

国产多烯紫杉醇及联合顺铂治疗非细胞肺癌临床研究 被引量:1

The domestically produced polyene taxus mellow and treats the non--cell lung cancer clinical research jointly along the platinum
原文传递
导出
摘要 目的:探讨国产多西紫杉醇(多帕菲,齐鲁制药)+顺铂联合化疗方案对非小细胞肺的临床疗效和安全性,并以进口多西紫杉醇(泰索帝)+顺铂联合化疗方案作对照。方法:患者随机分入多帕菲单用组(A组,31例):多帕菲75mg/m2i.v.d1+顺铂80mg/m2i.v.分3d用,每21d为1周期;泰索帝+顺铂组(B组,33例):泰索帝75mg/m2i.v.d1+顺铂80rag/m2i.v.分3d用,每21d为1周期。结果:入组的64例中59例可评价疗效,A、B组有效率分别为17.95%、21.62%。A和B组有效率相似。不良反应主要有中性粒细胞减少、贫血、粒细胞减少性发热、其他发热、脱发、恶心呕吐和乏力。B组中性粒细胞减少的发生率高于A组,两组间差异有显著性(P〈0.05)。其余不良反应两组相似。结论:国产多西紫杉醇(多帕菲)+顺铂与进口多西紫杉醇(泰索帝)+顺铂两联合化疗方案相似,对非小细胞肺癌有一定疗效,且毒性可耐受。 Objective:Discusses domestically produced many west taxuses mellow (the multi--handkerchief Philippines, the Qi and Lu drugs manufacture) + along the platinum union chemotherapy plan to the non--cellule lung's clinical curative effect and the security, and imports many west taxuses mellow (peaceful rope emperor) + to make the comparison along the platinum union chemotherapy plan. Methods:The patient enters multi--handkerchief Philippines Shan Yongzu along with the fuselage (A group, 31 examples) : Multi--handkerchief Philippines 75mg/m2 i. v. dl+ l, tivides 3d along platinum 80mg/m2 i.v. to use, each 21d is 1 cy- cle; Peaceful rope emperor + along platinum group (B group, 33 examples) : Peaceful rope Emperor 75mg/m2 i. v. dl+ divides 3d along platinum 80rag/m2 i.v. to use, each 21d is 1 cycle. Results:enters the group in 64. examples 59 examples to be possible to ap- praise the curative effect, A, B group of effectiveness respectively is 17.95%, 21.62~. A and B group of effectiveness are similar. The untoward effect mainly has the neutral granular cell to reduce, anemia, the granular cell reduction to give off heat, other to give off heat, to lose hair, the disgusting vomit and the asthenia. B group of neutral granular cell reduces the formation rate is higher than A group, two groups of differences have the significance (P〈0.05). Other untoward effect two group of similar. Conclusion: Domestically produced many west taxuses mellow (the multi--handkerchief Philippines) -I- with imports many west taxuses along the platinum mellow (peaceful rope emperor) + to he similar along the platinum two union chemotherapy plan, has certain curative effect to the non--cellule lung cancer, and the toxicity may endure.
作者 程华
出处 《按摩与康复医学》 2010年第9期16-17,共2页 Chinese Manipulation and Rehabilitation Medicine
关键词 非小细胞肺癌 多西紫杉醇 顺铂 治疗 Non--cellule lung cancer Many west taxuses mellow Along platinum Treatment
  • 相关文献

参考文献6

二级参考文献30

  • 1[1]Rizvi NA. Docetaxel (taxotere) and gemcitabine in combination therapy. Semin Oncol,1999,26(3 Suppl 11)∶19-22.
  • 2[2]van Oosterom AT. Docetaxel (taxotere) and gemcitabine phase Ⅰand early phase Ⅱ studies: results to date and an overview of ongoing studies. Semin Oncol,1999,26(3 Suppl 10)∶8-11.
  • 3[3]Rizvi NA, Spiridonidis CH, Davis TH, et al. Docetaxel and gemcitabine combinations in non-small cell lung cancer. Semin Oncol,1999,26(5 Suppl 16)∶27-31.
  • 4[5]Hainsworth JD, Burris HA 3rd, Greco FA. Weekly administration of docetaxel (taxotere): summary of clinical data. Semin Oncol,1999,26(3 Suppl 10)∶19-24.
  • 5[6]Chu DT. Phase Ⅰ trial of weekly docetaxel (D) plus cisplatin (C) in the treatment of advanced NSCLC in Chinese patients. Proc Am Soc Clin Oncol,2002,21∶2744.
  • 6[7]Spiridonidis CH, Laufman LR, Jones J, et al. Phase Ⅰ study of docetaxel dose escalation in combination with fixed weekly gemcitabine in patients with advanced malignancies. J Clin Oncol,1998,16(12)∶3866-3873.
  • 7[9]Georgoulias V, Papadakis E, Alexopoulos A, et al. Greek Oncology Cooperative Group (GOCG) for Lung Cancer. Platinumbased and non-platinum-based chemotherapy in advanced nonsmall-cell lung cancer: A randomised multicentre trial[J]. Lancet, 2001;357(9267):1478-1484.
  • 8[10]Patel R, Keiser LW, Justice GR. Acorn 9901: A multicenter randomized trial of weekly docetaxel-gemcitabine versus weekly paclitaxel-gemcitabine in patients (pts) with non- small cell lung cancer (NSCLC) (Abstr 1276)[J]. Proc Am Soc Clin Oncol, 2002;20(2):279b.
  • 9[11]Kosmas C, Tsavaris N, Vadiaka M, et al. Gemcitabine and docetaxel as second-line chemotherapy in non-small cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens[J]. Cancer, 2001;92(11):2902-2910.
  • 10[12]Kakolyris S, Papadakis E, Tsiafaki X, et al. Greek Cooperative Group for Lung Cancer. Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study[J]. Lung Cancer, 2001;32(2):179-187.

共引文献19

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部